Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRUKER CORPBRKR · Entity 3609 | Director | February 15, 2026 | February 18, 2026 |
| SI-BONE, Inc.SIBN · Entity 2501 | Director · Chief Executive Officer | October 12, 2026 | October 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRUKER CORP
Report date February 15, 2026 · Filed February 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,018 |
Reported balance
After 2026-02-15 transaction · row 1
1 source rowRow 1 · 2026-02-15 · Grant · Acquired 4,520 · Balance 9,018 F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.
SI-BONE, Inc.
Report date October 12, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Indirectby Trust | 379,256 |
Reported balance
After 2026-10-12 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-10-12 · Sale · Disposed 38,006 · Balance 379,256 F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 21, 2026. F2: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.1050, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F3: Reflects the transfer of shares from the Reporting Person to The David & Laura Joint Rev Tr. F4: Shares held by The David & Laura Joint Rev Tr. |
| Common StockSEC Table I · non-derivative | Direct | 368,129 |
Reported balance
Holding disclosure · report date 2026-10-12 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 368,129 F5: Includes 355,697 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 21, 2026.
F2: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.1050, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
F3: Reflects the transfer of shares from the Reporting Person to The David & Laura Joint Rev Tr.
F4: Shares held by The David & Laura Joint Rev Tr.
F5: Includes 355,697 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Shockwave Medical, Inc.
Report date May 31, 2024 · Filed May 31, 2024
Section 16 reporting ended · disclosed 2024-05-31. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-05-31 transaction · row 1
1 source rowRow 1 · 2024-05-31 · Disposition to issuer · Disposed 1,233 · Balance 0 F1: This Form 4 reports the disposition of securities pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 4, 2024, by and among the Issuer, Johnson & Johnson ("J&J"), and Sweep Merger Sub, Inc., a wholly owned subsidiary of J&J ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), effective as of the effective time of the Merger (the "Effective Time"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J. As a result of the Merger, at the Effective Time, each outstanding share of common stock, par value $0.001 per share, of the Issuer ("Common Stock") outstanding immediately prior to the Effective Time (excluding Excluded Shares and any Dissenting Company Shares, each as defined in the Merger Agreement) was automatically converted into the right to receive $335.00 in cash (the "Merger Consideration"), F2: (Continued from Footnote 1) without interest and less any applicable withholding taxes. Additionally, pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time and (ii) the Merger Consideration. |
| Common StockSEC Table I · non-derivative | IndirectDavid and Laura Francis Joint Rev Trust | 0 |
Reported balance
After 2024-05-31 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2024-05-31 · Disposition to issuer · Disposed 3,551 · Balance 0 F1: This Form 4 reports the disposition of securities pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 4, 2024, by and among the Issuer, Johnson & Johnson ("J&J"), and Sweep Merger Sub, Inc., a wholly owned subsidiary of J&J ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), effective as of the effective time of the Merger (the "Effective Time"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J. As a result of the Merger, at the Effective Time, each outstanding share of common stock, par value $0.001 per share, of the Issuer ("Common Stock") outstanding immediately prior to the Effective Time (excluding Excluded Shares and any Dissenting Company Shares, each as defined in the Merger Agreement) was automatically converted into the right to receive $335.00 in cash (the "Merger Consideration"), F2: (Continued from Footnote 1) without interest and less any applicable withholding taxes. Additionally, pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time and (ii) the Merger Consideration. F3: These shares are held in a trust for the benefit of the reporting person's children. The reporting person and the reporting person's spouse are trustees of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $6.59 · Expires 2029-02-01 | Direct | 0 |
Reported balance
After 2024-05-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-05-31 · Disposition to issuer · Disposed 13,690 · Balance 0 F4: Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock ("Company Option") that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price that was less than the Merger Consideration, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 reports the disposition of securities pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 4, 2024, by and among the Issuer, Johnson & Johnson ("J&J"), and Sweep Merger Sub, Inc., a wholly owned subsidiary of J&J ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), effective as of the effective time of the Merger (the "Effective Time"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J. As a result of the Merger, at the Effective Time, each outstanding share of common stock, par value $0.001 per share, of the Issuer ("Common Stock") outstanding immediately prior to the Effective Time (excluding Excluded Shares and any Dissenting Company Shares, each as defined in the Merger Agreement) was automatically converted into the right to receive $335.00 in cash (the "Merger Consideration"),
F2: (Continued from Footnote 1) without interest and less any applicable withholding taxes. Additionally, pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time and (ii) the Merger Consideration.
F3: These shares are held in a trust for the benefit of the reporting person's children. The reporting person and the reporting person's spouse are trustees of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4: Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock ("Company Option") that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price that was less than the Merger Consideration, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 12, 2026 Filed Oct 14, 2026 21:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 38,006 | $20.05 | $762,012.70 |
DisclosureSEC source: 0001218802-26-000006 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 379,256 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 21, 2026. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.1050, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F3 · balance_after: Reflects the transfer of shares from the Reporting Person to The David & Laura Joint Rev Tr. F4 · ownership.nature: Shares held by The David & Laura Joint Rev Tr. Read SEC document |
| August 24, 2026 Filed Aug 26, 2026 23:06 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 25,972 | $20.12 | $522,595.60 |
DisclosureSEC source: 0001218802-26-000005 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 291,491 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 21, 2026. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.24, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F3 · ownership.nature: Shares held by The David & Laura Joint Rev Tr. Read SEC document |
| August 21, 2026 Filed Aug 21, 2026 21:58 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,923 | $20.02 | $78,538.46 |
DisclosureSEC source: 0001218802-26-000004 · primarydocument.xml · nonDerivative · entry 2 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 317,463 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 21, 2026. F4 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.05, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F3 · ownership.nature: Shares held by The David & Laura Joint Rev Tr. Read SEC document |
| August 20, 2026 Filed Aug 21, 2026 21:58 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 51,884 | $19.46 | $1,009,662.64 |
DisclosureSEC source: 0001218802-26-000004 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 321,386 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 21, 2026. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.10 to $19.73, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F3 · ownership.nature: Shares held by The David & Laura Joint Rev Tr. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 21:00 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,973 | $18.63 | $36,754.82 |
DisclosureSEC source: 0001218802-26-000003 · primarydocument.xml · nonDerivative · entry 5 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 493,900 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $18.55 USD to $18.73 USD; the price reported above reflects the weighted average sale price. F5 · balance_after: Includes 355,697 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F6 · balance_after: Reflects the transfer of shares from the Reporting Person to The David & Laura Joint Rev Tr. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 21:00 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,236 | $18.68 | $41,771.61 |
DisclosureSEC source: 0001218802-26-000003 · primarydocument.xml · nonDerivative · entry 4 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 490,461 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $18.52 USD to $18.79 USD; the price reported above reflects the weighted average sale price. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 21:00 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,203 | $18.66 | $59,777.59 |
DisclosureSEC source: 0001218802-26-000003 · primarydocument.xml · nonDerivative · entry 3 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 492,697 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $18.52 USD to $18.77 USD; the price reported above reflects the weighted average sale price. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 21:00 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,652 | $18.66 | $68,144.49 |
DisclosureSEC source: 0001218802-26-000003 · primarydocument.xml · nonDerivative · entry 2 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 495,900 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $18.52 USD to $18.77 USD; the price reported above reflects the weighted average sale price. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 21:00 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,892 | $18.66 | $72,616.16 |
DisclosureSEC source: 0001218802-26-000003 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 499,552 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $18.52 USD to $18.77 USD; the price reported above reflects the weighted average sale price. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,203 | $14.73 | $47,171.54 |
DisclosureSEC source: 0001218802-26-000002 · primarydocument.xml · nonDerivative · entry 5 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 503,444 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F5 · price: This transaction was executed in multiple trades at prices ranging from $14.33 USD to $14.85 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · balance_after: Includes 1,395 shares acquired under the SI-BONE, Inc 2018 Employee Stock Purchase Plan on May 15, 2026. F7 · balance_after: Reflects the transfer of shares from the Reporting Person to The David & Laura Joint Rev Tr. F8 · balance_after: Includes 385,070 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,652 | $14.75 | $53,866.63 |
DisclosureSEC source: 0001218802-26-000002 · primarydocument.xml · nonDerivative · entry 4 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 532,615 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $14.34 USD to $14.87 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,973 | $14.57 | $28,745.43 |
DisclosureSEC source: 0001218802-26-000002 · primarydocument.xml · nonDerivative · entry 3 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 536,267 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $14.35 USD to $14.85 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,236 | $14.67 | $32,813.08 |
DisclosureSEC source: 0001218802-26-000002 · primarydocument.xml · nonDerivative · entry 2 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 538,240 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $14.35 USD to $14.85 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,893 | $14.75 | $57,403.45 |
DisclosureSEC source: 0001218802-26-000002 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 540,476 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $14.34 USD to $14.84 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 00:15 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,033 | $15.30 | $31,094.94 |
DisclosureSEC source: 0001218802-26-000001 · primarydocument.xml · nonDerivative · entry 11 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 544,369 F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F7 · price: This transaction was executed in multiple trades at prices ranging from $15.13 USD to $15.51 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F9 · balance_after: Includes 414,439 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 00:15 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 7,888 | $15.44 | $121,760.75 |
DisclosureSEC source: 0001218802-26-000001 · primarydocument.xml · nonDerivative · entry 10 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 546,402 F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F8 · price: This transaction was executed in multiple trades at prices ranging from $15.24 USD to $15.62 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 00:15 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,236 | $15.29 | $34,199.40 |
DisclosureSEC source: 0001218802-26-000001 · primarydocument.xml · nonDerivative · entry 9 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 554,290 F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F7 · price: This transaction was executed in multiple trades at prices ranging from $15.13 USD to $15.51 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 00:15 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,203 | $15.31 | $49,046.90 |
DisclosureSEC source: 0001218802-26-000001 · primarydocument.xml · nonDerivative · entry 8 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 556,526 F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F7 · price: This transaction was executed in multiple trades at prices ranging from $15.13 USD to $15.51 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 00:15 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 39,764 | $15.29 | $608,067.11 |
DisclosureSEC source: 0001218802-26-000001 · primarydocument.xml · nonDerivative · entry 7 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 559,729 F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F6 · price: This transaction was executed in multiple trades at prices ranging from $15.13 USD to $15.62 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 00:15 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 18,889 | $15.32 | $289,434.26 |
DisclosureSEC source: 0001218802-26-000001 · primarydocument.xml · nonDerivative · entry 6 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 599,493 F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F6 · price: This transaction was executed in multiple trades at prices ranging from $15.13 USD to $15.62 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 00:15 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,893 | $15.29 | $59,510.73 |
DisclosureSEC source: 0001218802-26-000001 · primarydocument.xml · nonDerivative · entry 5 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 618,382 F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F5 · price: This transaction was executed in multiple trades at prices ranging from $15.15 USD to $15.53 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 00:15 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 15,569 | $15.35 | $239,007.50 |
DisclosureSEC source: 0001218802-26-000001 · primarydocument.xml · nonDerivative · entry 4 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 622,275 F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $15.12 USD to $15.62 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2026 Filed Feb 19, 2026 00:15 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 57,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001218802-26-000001 · primarydocument.xml · nonDerivative · entry 3 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 637,844 F2 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest, if at all, over three years based on the Issuer's total shareholder return (TSR) as measured against the TSR of the company at the median of the range TSRs of a set of peer companies established by the Issuer as set forth in the grant. Read SEC document |
| February 16, 2026 Filed Feb 19, 2026 00:15 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 57,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001218802-26-000001 · primarydocument.xml · nonDerivative · entry 2 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 580,474 F2 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest, if at all, over three years based on the Issuer's total shareholder return (TSR) as measured against the TSR of the company at the median of the range TSRs of a set of peer companies established by the Issuer as set forth in the grant. Read SEC document |
| February 16, 2026 Filed Feb 19, 2026 00:15 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 114,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001218802-26-000001 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 523,104 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest over four years beginning on February 15, 2026, and will be released in quarterly installments, subject to the Reporting Person's continued service through each relevant vesting date. Read SEC document |
| February 15, 2026 Filed Feb 18, 2026 21:38 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 4,520 | $0.00 | $0.00 |
DisclosureSEC source: 0000929638-26-000682 · form4.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,018 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 00:02 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 5,411 | $17.70 | $95,762.80 |
DisclosureSEC source: 0001218802-25-000005 · primarydocument.xml · nonDerivative · entry 5 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 351,319 F6 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 13th, 2024. F7 · price: This transaction was executed in multiple trades at prices ranging from $17.46 USD to $17.91 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote F8 · ownership.nature: Shares held by The David & Laura Joint Rev Tr. Read SEC document |
| November 17, 2025 Filed Nov 20, 2025 00:02 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,885 | $17.40 | $67,597.45 |
DisclosureSEC source: 0001218802-25-000005 · primarydocument.xml · nonDerivative · entry 4 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 408,363 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $17.295 USD to $17.57 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · balance_after: Includes 373,980 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 17, 2025 Filed Nov 20, 2025 00:02 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,197 | $17.43 | $55,736.82 |
DisclosureSEC source: 0001218802-25-000005 · primarydocument.xml · nonDerivative · entry 3 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 412,248 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $17.295 USD to $17.57 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2025 Filed Nov 20, 2025 00:02 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,231 | $17.44 | $38,919.57 |
DisclosureSEC source: 0001218802-25-000005 · primarydocument.xml · nonDerivative · entry 2 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 415,445 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $17.28 USD to $17.56 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2025 Filed Nov 20, 2025 00:02 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,028 | $17.44 | $35,368.52 |
DisclosureSEC source: 0001218802-25-000005 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 417,676 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $17.31 USD to $17.56 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 5,411 | $17.06 | $92,306.79 |
DisclosureSEC source: 0001218802-25-000004 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 356,730 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 13th, 2024. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.00 to $17.24, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F3 · ownership.nature: Shares held by The David & Laura Joint Rev Tr. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 21:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,885 | $15.59 | $60,573.37 |
DisclosureSEC source: 0001562180-25-005920 · primarydocument.xml · nonDerivative · entry 4 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 419,704 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F5 · price: This transaction was executed in multiple trades at prices ranging from $15.50 USD to $15.81 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · balance_after: Includes 396,297 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 21:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,197 | $15.59 | $49,847.94 |
DisclosureSEC source: 0001562180-25-005920 · primarydocument.xml · nonDerivative · entry 3 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 423,589 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $15.50 USD to $15.83 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 21:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,029 | $15.62 | $31,687.91 |
DisclosureSEC source: 0001562180-25-005920 · primarydocument.xml · nonDerivative · entry 2 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 426,786 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $15.50 USD to $15.80 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 21:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,232 | $15.61 | $34,830.58 |
DisclosureSEC source: 0001562180-25-005920 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 428,815 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.52 USD to $15.83 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 07, 2025 Filed Jul 8, 2025 00:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 757 | $18.26 | $13,822.82 |
DisclosureSEC source: 0001562180-25-005343 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · by Trust Disclosed balance after: 362,141 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · balance_after: Reflects the transfer of shares from the Reporting Person to The David & Laura Joint Rev Tr. F3 · ownership.nature: Shares held by The David & Laura Joint Rev Tr. Read SEC document |
| May 19, 2025 Filed May 20, 2025 23:48 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 5,412 | $19.49 | $105,463.64 |
DisclosureSEC source: 0001562180-25-004057 · primarydocument.xml · nonDerivative · entry 9 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 490,987 F7 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F8 · price: This transaction was executed in multiple trades at prices ranging from $19.26 USD to $19.64 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F9 · balance_after: Includes 2,023 shares acquired under the SI-BONE, Inc. 2018 Employee Stock Purchase Plan on May 15, 2025. F10 · balance_after: Includes 418,615 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 16, 2025 Filed May 20, 2025 23:48 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 794 | $19.48 | $15,467.20 |
DisclosureSEC source: 0001562180-25-004057 · primarydocument.xml · nonDerivative · entry 8 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 496,399 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F6 · price: This transaction was executed in multiple trades at prices ranging from $18.98 USD to $19.955 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2025 Filed May 20, 2025 23:48 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,231 | $19.68 | $43,908.76 |
DisclosureSEC source: 0001562180-25-004057 · primarydocument.xml · nonDerivative · entry 7 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 495,170 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $19.01 USD to $20.005 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2025 Filed May 20, 2025 23:48 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 100 | $20.01 | $2,001.00 |
DisclosureSEC source: 0001562180-25-004057 · primarydocument.xml · nonDerivative · entry 6 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 497,401 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| May 16, 2025 Filed May 20, 2025 23:48 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 100 | $20.01 | $2,001.00 |
DisclosureSEC source: 0001562180-25-004057 · primarydocument.xml · nonDerivative · entry 5 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 497,501 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| May 16, 2025 Filed May 20, 2025 23:48 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,097 | $19.68 | $60,943.08 |
DisclosureSEC source: 0001562180-25-004057 · primarydocument.xml · nonDerivative · entry 4 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 497,601 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F5 · price: This transaction was executed in multiple trades at prices ranging from $19.01 USD to $20.00 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2025 Filed May 20, 2025 23:48 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,785 | $19.66 | $74,420.67 |
DisclosureSEC source: 0001562180-25-004057 · primarydocument.xml · nonDerivative · entry 3 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 500,698 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $19.00 USD to $19.96 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2025 Filed May 20, 2025 23:48 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,028 | $19.69 | $39,926.66 |
DisclosureSEC source: 0001562180-25-004057 · primarydocument.xml · nonDerivative · entry 2 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 504,483 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $19.01 USD to $20.005 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2025 Filed May 20, 2025 23:48 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 250 | $20.01 | $5,002.00 |
DisclosureSEC source: 0001562180-25-004057 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 506,511 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.00 USD to $20.01 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:08 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 4,498 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-013660 · form4-05192025_090523.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,498 F1 · acquired: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on May 15, 2026. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| May 07, 2025 Filed May 9, 2025 23:01 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 38,504 | $17.18 | $661,367.81 |
DisclosureSEC source: 0001562180-25-003727 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 302,958 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.00 to $17.59, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F3 · ownership.nature: Shares by The David & Laura Francis Joint Rev Tr. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 21:19 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 5,031 | $17.03 | $85,662.33 |
DisclosureSEC source: 0001562180-25-001488 · primarydocument.xml · nonDerivative · entry 11 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 506,761 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F8 · price: This transaction was executed in multiple trades at prices ranging from $16.35 USD to $17.345 USD; the price reported above reflects the weighted average sale price. F11 · balance_after: Includes 442,987 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 21:19 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 5,017 | $17.04 | $85,512.76 |
DisclosureSEC source: 0001562180-25-001488 · primarydocument.xml · nonDerivative · entry 10 FRANCIS LAURA · CIK 0001218802 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 511,792 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F10 · price: This transaction was executed in multiple trades at prices ranging from $16.36 USD to $17.35 USD; the price reported above reflects the weighted average sale price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.